CN Healthy Food Tech Group (UCFI) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

CN Healthy Food Tech Group

NasdaqCM•Consumer Defensive•Packaged Foods

$5.51-0.00(<0.01%)Market closed

Market Cap

$287.81M

P/E

47.7x

P/S

12.8x

P/B

12.3x

CN Healthy Food Tech Group Corp., together with its subsidiaries, engages in the research and development, production, and sale of bio-health food in the People's Republic of China. It operates through two segments, Wholesale Distribution and Live-Stream Sales. The company offers cordyceps peptide selenium powders, Baofei granule extract plant drinks, Yancui peptide selenium powders, Ganoderma lucidum and matsutake peptide selenium powders, ginseng peptide selenium powders, collagen peptide prebiotic drinks, plant essential oils, and Shangshangyi congee products. It sells its products through e-commerce and social platforms; and offline dealers. CN Healthy Food Tech Group Corp. was founded in 2024 and is based in Zhuhai, the People's Republic of China.

How this company scores

AverageMetricSide Score: 55/100

Strongest: Profitability (25/25); weakest: Cash & Earnings Quality (0/25).

Profitability25/25

Growth15/25

Balance Sheet & Red Flags15/25

Cash & Earnings Quality0/25

Strengths

Strong marginsHigh ROERising earningsInterest easily covered

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 47.7x5y range 47.7x – 151.8x

Currently below its 7-quarter median.

P/S · 12.8x5y range 12.8x – 62.4x

P/B · 12.3x5y range 12.3x – 27.8x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

Free cash flow has been negative in 8 of the last 8 quarters — earnings are not translating to cash.

Price & Volume

Market Cap $287.81M

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $22.47M
Q. Revenue: $8.73M
TTM EBITDA: $10.38M
TTM Op. Income: $9.76M
Q. Op. Income: $5.12M
TTM Net Income: $6.03M
Q. Net Income: $3.06M
EPS: $0.06
Shares Out.: $52.23M

$22.47M in TTM revenue grew from zero YoY, reaching $8.73M last quarter. TTM EBITDA of $10.38M and TTM operating income of $9.76M show growth is flowing through to the bottom line. TTM net income of $6.03M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 3 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 71.5%
EBITDA Margin: 60.2%
Op. Margin: 58.6%
Net Margin: 35.0%

Op. margin of 58.6% is up 51995858.6% YoY — cost efficiency is improving. Net margin at 35.0% and gross margin of 71.5% show how much of each revenue dollar survives to profit. Over the past year, operating margin is up 100% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 47.7x
P/S Ratio: 12.8x
P/B Ratio: 12.3x

At 47.7x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 12.8x and P/B of 12.3x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 7 quarters, P/E has fallen for 3 consecutive quarters — an improving trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $35.21M
Cash: $23.32M
Long-Term Debt: N/A
Book Value: $23.35M
D/E Ratio: N/A
Debt/EBITDA: 0.0

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $-7.03M
TTM Free Cash Flow: $-16.38M
FCF Margin: -72.9%
FCF / Net Income: -2.7

TTM FCF of $-16.38M on $-7.03M in operating cash flow. The FCF / Net Income ratio of -2.7x means the business consumes cash — it is not yet self-funding. Across the last 8 quarters, free cash flow has fallen for 7 consecutive quarters — a weakening trend.